Diffuse Large Cell Lymphoma
Oncology·MeSH: Lymphoma, Large B-Cell, Diffuse
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
Phase 4(1)
| Drug | Company |
|---|---|
| Pomalidomide | Filana Therapeutics Inc. (FLNA) |
Frequently asked questions
How many drugs are in development for Diffuse Large Cell Lymphoma?
BioSniper tracks 2 drugs in development for Diffuse Large Cell Lymphoma across 2 companies.
How many clinical trials target Diffuse Large Cell Lymphoma?
There are 1 clinical trial targeting Diffuse Large Cell Lymphoma tracked by BioSniper.
What is the prevalence of Diffuse Large Cell Lymphoma?
The estimated prevalence of Diffuse Large Cell Lymphoma is approximately 56.0 per 100,000 population.
Deep-dive into Diffuse Large Cell Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis